Scientific reports

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

acta neuropathologica communications

Journal of Alzheimer's disease : JAD

frontiers in neurology

Biochemistry and biophysics reports

Regenerative therapy

current alzheimer research

journal of neurology, neurosurgery, and psychiatry

neurotherapeutics : the journal of the american society for experimental neurotherapeutics

[1] Development and assessment of the inter-rater and intra-rater reproducibility of a self-administration version of the ALSFRS-R.

[2] Sarm1 deletion suppresses TDP-43-linked motor neuron degeneration and cortical spine loss.

[3] Ropinirole hydrochloride remedy for amyotrophic lateral sclerosis - Protocol for a randomized, double-blind, placebo-controlled, single-center, and open-label continuation phase I/IIa clinical trial (ROPALS trial).

[4] Elevated cerebrospinal fluid homocysteine is associated with blood-brain barrier disruption in amyotrophic lateral sclerosis patients.

[5] A model for gain of function in superoxide dismutase.

[6] risk agents related to work and amyotrophic lateral sclerosis: an occupational medicine focus

[7] survival prediction in amyotrophic lateral sclerosis based on mri measures and clinical characteristics

[8] focus on the role of d-serine and d-amino acid oxidase in amyotrophic lateral sclerosis/motor neuron disease (als)

[9] epidural anesthesia combined with sedation with dexmedetomidine for appendectomy in a patient with amyotrophic lateral sclerosis: a case report

[10] skeletal muscle satellite cells, mitochondria and micrornas: their involvement in the pathogenesis of als

[11] molecular diagnostics of neurodegenerative disorders

[12] the split hand sign

[13] alterations in the stomatognathic system due to amyotrophic lateral sclerosis

[14] sialorrhoea: how to manage a frequent complication of motor neuron disease

[15] two case reports of an unusual association between klippel-feil syndrome and amyotrophic lateral sclerosis: do they share same genetic defect?

[16] Withaferin-A Treatment Alleviates TAR DNA-Binding Protein-43 Pathology and Improves Cognitive Function in a Mouse Model of FTLD.

[17] Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2.

[18] circadian rhythm dysfunction accelerates disease progression in a mouse model with amyotrophic lateral sclerosis

[19] the involvement of micrornas in neurodegenerative diseases

[20] lessons of als imaging: pitfalls and future directions — a critical review

[21] the role of the innate immune system in als

[22] vascular endothelial growth factor (vegf) prevents the downregulation of the cholinergic phenotype in axotomized motoneurons of the adult rat

[23] Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis

[24] The multidimensional nature of dyspnoea in amyotrophic lateral sclerosis patients with chronic respiratory failure: Air hunger, anxiety and fear

[25] Predicting Development of Amyotrophic Lateral Sclerosis in Frontotemporal Dementia.

[26] Amyotrophic Lateral Sclerosis and Primary Biliary Cirrhosis Overlap Syndrome: Two Cases Report.

[27] Autopsy findings in the early stage of amyotrophic lateral sclerosis with "dropped head" syndrome.

[28] Stability of a chronic implanted brain-computer interface in late-stage amyotrophic lateral sclerosis

[29] Split-hand index in amyotrophic lateral sclerosis: an F-wave study.

[30] Dysphagia in amyotrophic lateral sclerosis: Impact on patient behavior, diet adaptation, and riluzole management

[31] Information-seeking behavior and information needs in patients with amyotrophic lateral sclerosis

[32] Ropinirole hydrochloride remedy for amyotrophic lateral sclerosis - Protocol for a randomized, double-blind, placebo-controlled, single-center, and open-label continuation phase I/IIa clinical trial (ROPALS trial).

[33] Is the evidence strong enough for acupuncture ameliorates clinical symptoms in patients with amyotrophic lateral sclerosis: A protocol for a systematic review and meta-analysis.

[34] The role of gut microbiota, butyrate and proton pump inhibitors in amyotrophic lateral sclerosis: a systematic review.

[35] Exploring sarcasm detection in amyotrophic lateral sclerosis using ecologically valid measures.

[36] Exploring sarcasm detection in Amyotrophic Lateral Sclerosis using ecologically valid measures

[37] The influence of metallothionein treatment and treadmill running exercise on disease onset and survival in SOD1 amyotrophic lateral sclerosis mice.

[38] Exome sequencing in amyotrophic lateral sclerosis implicates a novel gene, DNAJC7, encoding a heat-shock protein.

[39] Multi-disciplinary clinical protocol for the diagnosis of bulbar amyotrophic lateral sclerosis.

[40] The established and emerging roles of astrocytes and microglia in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.

[41] Elevated cerebrospinal fluid homocysteine is associated with blood-brain barrier disruption in amyotrophic lateral sclerosis patients.

[42] Toward in vivo determination of peripheral nervous system immune activity in amyotrophic lateral sclerosis.

[43] Amyotrophic lateral sclerosis with ophthalmoplegia and multisystem degeneration in patients on long-term use of respirators

[44] Ultrastructural study of chromatolytic neurons in an adult-onset sporadic case of amyotrophic lateral sclerosis

[45] Immunocytochemical and ultrastructural study of pericapillary rosettes in amyotrophic lateral sclerosis

[46] risk agents related to work and amyotrophic lateral sclerosis: an occupational medicine focus

[47] adeno-associated viral vector delivered rnai for gene therapy of sod1 amyotrophic lateral sclerosis

[48] the relationship between depressive symptoms, disease state, and cognition in amyotrophic lateral sclerosis.

[49] survival prediction in amyotrophic lateral sclerosis based on mri measures and clinical characteristics

[50] dipals: diaphragm pacing in patients with amyotrophic lateral sclerosis – a randomised controlled trial

[51] focus on the role of d-serine and d-amino acid oxidase in amyotrophic lateral sclerosis/motor neuron disease (als)

[52] structural and diffusion imaging versus clinical assessment to monitor amyotrophic lateral sclerosis

[53] an iranian familial amyotrophic lateral sclerosis pedigree with p.val48phe causing mutation in sod1: a genetic and clinical report

[54] epidural anesthesia combined with sedation with dexmedetomidine for appendectomy in a patient with amyotrophic lateral sclerosis: a case report

[55] lack of association between nuclear factor erythroid-derived 2-like 2 promoter gene polymorphisms and oxidative stress biomarkers in amyotrophic lateral sclerosis patients

[56] alterations in the stomatognathic system due to amyotrophic lateral sclerosis

[57] communication of diagnosis in amyotrophic lateral sclerosis: stratification of patients for the estimation of the individual needs

[58] the utility of independent component analysis and machine learning in the identification of the amyotrophic lateral sclerosis diseased brain.

[59] two case reports of an unusual association between klippel-feil syndrome and amyotrophic lateral sclerosis: do they share same genetic defect?

[60] circadian rhythm dysfunction accelerates disease progression in a mouse model with amyotrophic lateral sclerosis

[61] amyotrophic lateral sclerosis and multiple sclerosis overlap: a case report

[62] administration of recombinant heat shock protein 70 delays peripheral muscle denervation in the sod1g93a mouse model of amyotrophic lateral sclerosis

[63] writing errors and anosognosia in amyotrophic lateral sclerosis with dementia

[64] increased il-17, a pathogenic link between hepatosplenic schistosomiasis and amyotrophic lateral sclerosis: a hypothesis

[65] genetic correction of sod1 mutant ipscs reveals erk and jnk activated ap1 as a driver of neurodegeneration in amyotrophic lateral sclerosis

[66] blood biomarkers for amyotrophic lateral sclerosis: myth or reality?

[67] early gene expression changes in spinal cord from sod1g93a amyotrophic lateral sclerosis animal model

[68] cellular and molecular mechanisms of motor neuron death in amyotrophic lateral sclerosis: a perspective

[69] Correction to: A novel splicing variant of ANXA11 in a patient with amyotrophic lateral sclerosis: histologic and biochemical features

[70] A novel splicing variant of ANXA11 in a patient with amyotrophic lateral sclerosis: histologic and biochemical features

[71] Small peptide CSF fingerprint of amyotrophic lateral sclerosis.